Skyhawk Therapeutics announced positive 9-month interim findings from its phase 1 clinical trial of SKY-0515 for the treatment of #HuntingtonDisease (HD).
Read more: https://bit.ly/4tbDFl3
#RareDisease #SKY0515 #SkyhawkTherapeutics
2
0
0
0